John G.F. Cleland
National Institutes of Health
1299 Papers
11.2K Citations
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 137, co-authored 1172 publications. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Chat about Author
Papers
La terapia de resincronización es coste-efectiva
TL;DR: Todos los autores recibieron financiacion para la asistencia a reuniones y para realizar el trabajo relacionado with el ensayo and realizaron los analisis de coste-efectividad.
4
Left ventricular non-compaction with congenital diaphragmatic hernia causing cardiac dextroposition
Paweł Rubiś,Tomasz Miszalski-Jamka,John G.F. Cleland,Zbigniew Gąsior,Jakub Podolec,Magdalena Kostkiewicz,Agata Leśniak‑Sobelga,Maciej Krupiński,Piotr Podolec +8 more
TL;DR: This case is an illustrate of a constellation of rare anomalies of LVNC, persistent left superior vena cava with a congenital anterior Morgagni-type diaphragm hernia, causing heart dextroposition, causing LV non-compaction.
Letter by Begg et al Regarding Article, “The Effects of Vitamin D Supplementation on Physical Function and Quality of Life in Older Heart Failure Patients: A Randomized Controlled Trial”
TL;DR: Concerns are raised about the patient selection and the nature of the supplement that might attenuate their neutral conclusion that vitamin D supplementation does not improve quality of life or physical functioning in older patients with chronic heart failure.
4
Renin and angiotensin responses to posture and exercise in elderly patients with heart failure
TL;DR: This study implies that the efficacy of angiotensin converting enzyme inhibitors is likely to be maintained in the elderly patient with heart failure.
4
Extra-cardiac targets in the management of cardiometabolic disease: Device-based therapies.
Ana Jorbenadze,Marat Fudim,Marat Fudim,Felix Mahfoud,Phillip B Adamson,Tarek Bekfani,Rolf Wachter,Horst Sievert,Piotr Ponikowski,John G.F. Cleland,Stefan D. Anker +10 more
TL;DR: In this paper, a review of device-based therapies using neuromodulation of extra-cardiac targets to treat cardiometabolic disease was presented, which showed substantial effects in patients with heart failure with preserved ejection fraction.
4